Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The center specialized in minimally invasive MRI-guided focal laser ablation and TULSA-PRO procedures for prostate cancer and BPH. Over several years, hundreds of patients were treated with high rates of success and low side effects reported. After acquisition by HALO Diagnostics in 2020, the clinic continued to advance these technologies until its closure as an independent entity in March 2024. Patient testimonials report significant reductions in PSA levels post-procedure with minimal sexual or urinary side effects compared to traditional surgery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prostate Laser Center.